This company has been marked as potentially delisted and may not be actively trading. (ARPI) (ARPI) News Today Add Share Share Headlines Stock AnalysisBuy This Stock ARPI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Cellular signature explains why some prostate tumors resist standard treatmentsJuly 10, 2025 | msn.comStudy identifies why some prostate cancers fail to respond to treatmentJuly 9, 2025 | msn.comAI-designed inhibitor targets key enzyme to fight prostate cancer drug resistanceJuly 2, 2025 | msn.comDalai Lama alone can decide on reincarnation: French scholar ArpiJune 29, 2025 | msn.comXTANDI® (enzalutamide) now funded in Ontario for all approved prostate cancer indicationsJune 26, 2025 | finance.yahoo.comNovartis reports topline outcomes from trial of Pluvicto for prostate cancerJune 4, 2025 | msn.comPARP-ARPI Combo Sets New Standard for Metastatic Hormone-Sensitive Prostate CancerJune 4, 2025 | msn.comAstellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trialMay 23, 2025 | msn.comFDA approves Novartis radioligand therapy Pluvicto for earlier use in mCRPCMarch 29, 2025 | markets.businessinsider.comTalazoparib-Enzalutamide Improves Survival in Metastatic CRPCFebruary 16, 2025 | msn.comAdding Radioligand to Enzalutamide Boosts OS in Metastatic CRPCFebruary 14, 2025 | msn.comPfizer’s TALZENNA® in Combination with XTANDI® Improves Survival Outcomes in Metastatic Castration Resistant Prostate CancerFebruary 13, 2025 | finance.yahoo.comRedHill Biopharma launches trial of combination therapy for prostate cancerFebruary 5, 2025 | finance.yahoo.comRanji Trophy: Saurashtra take first-innings lead against JharkhandNovember 9, 2024 | msn.comLadakh disengagement taking place in 'orderly' manner: ChinaOctober 30, 2024 | msn.comIndian Army’s first brush with the PLA was in 1951. The windfall was Chushul airfieldOctober 24, 2024 | msn.comRadioligand Shows Promise in Metastatic Hormone-Sensitive Prostate CancerOctober 16, 2024 | msn.comMetastatic Castration-Sensitive Prostate Cancer Clinical Trial Pipeline Insights Featuring 35+ Companies | DelveInsightOctober 16, 2024 | finance.yahoo.comPfizer reports positive data from prostate cancer combination therapy trialOctober 12, 2024 | msn.comPfizer’s stock dips after two former execs say they won’t support Starboard, offer backing for CEO Albert BourlaOctober 10, 2024 | msn.comPfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 TrialOctober 10, 2024 | finance.yahoo.comPfizer announces positive data from late-stage trial of prostate cancer combo treatmentOctober 10, 2024 | marketwatch.comLNTH Oct 2024 105.000 callSeptember 24, 2024 | ca.finance.yahoo.comLNTH Oct 2024 125.000 putSeptember 24, 2024 | ca.finance.yahoo.comLNTH Oct 2024 125.000 callSeptember 19, 2024 | ca.finance.yahoo.comRecent Breakthroughs in Cancer Research Could Impact These Key CompaniesSeptember 19, 2024 | baystreet.caHistory, culture and kayaking combine in unassuming ArmeniaSeptember 19, 2024 | msn.comLNTH Jan 2025 77.500 callSeptember 18, 2024 | ca.finance.yahoo.comLNTH Jan 2026 110.000 callSeptember 17, 2024 | ca.finance.yahoo.comLNTH Jan 2025 57.500 putSeptember 17, 2024 | ca.finance.yahoo.comLNTH Oct 2024 100.000 callSeptember 17, 2024 | ca.finance.yahoo.comESMO 2024: Eli Lilly brings the competition to Novartis with new results in mCRPCSeptember 17, 2024 | finance.yahoo.comORIC Pharmaceuticals, Inc. (ORIC): Short Seller Sentiment is Bearish on This Cancer StockSeptember 15, 2024 | msn.comPfizer Highlights Diverse Oncology Portfolio and Combination Approaches at ESMO 2024September 11, 2024 | finance.yahoo.comPrecision therapy for metastatic prostate cancer offers improved survivalAugust 21, 2024 | msn.comTibetan govt-in-exile plans to draw map of Tibet with original names of placesJuly 21, 2024 | msn.com'China fails to win hearts and minds of Tibetan people': Former envoyJuly 19, 2024 | msn.comResearchers discuss metastatic castration resistant prostate cancerJuly 19, 2024 | msn.comCyclone Remal: 36 Dead In 4 States As Heavy Rains & Landslides Leave Trail Of Destruction Across North-East India; Visuals SurfaceMay 28, 2024 | msn.comALLPack Indonesia 2024 showcases industry leaders in Packaging, Printing and ManufacturingMay 15, 2024 | sg.finance.yahoo.comArpita Khan, Ayush Sharma Getting Divorced? Here's What We KnowMay 10, 2024 | msn.comHolding On To History: Eccentric MLB legend ended career with Iron Range teamMay 8, 2024 | msn.comChina building new road in occupied Kashmir near Siachen: Satellite imagesApril 25, 2024 | msn.comOn your marks: The 2024 Daily News girls swimming & diving all-starsApril 24, 2024 | sports.yahoo.comWhy Is Novartis Stock Trading Higher On Thursday?April 4, 2024 | msn.comRombout Middle School Honor RollMarch 16, 2024 | msn.comClarity's theranostic prostate cancer trial advances to multi-dose phaseMarch 15, 2024 | finance.yahoo.comDrought hits Bataan, Zambales; crop losses in Negros at P14.4 millionFebruary 15, 2024 | msn.comVersant’s radiation assessor Qdose wins FDA clearanceJanuary 8, 2024 | msn.comLantheus Stock: Looking To Add After SPLASH's Belly-FlopDecember 20, 2023 | seekingalpha.com Get (ARPI) News Delivered to You Automatically Sign up to receive the latest news and ratings for ARPI and its competitors with MarketBeat's FREE daily newsletter. Email Address ARPI Media Mentions By Week ARPI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARPI News Sentiment▼0.000.62▲Average News Sentiment ARPI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARPI Articles This Week▼00▲ARPI Articles Average Week Get (ARPI) News Delivered to You Automatically Sign up to receive the latest news and ratings for ARPI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ARPI) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ARPI) Please log in to your account or sign up in order to add this asset to your watchlist. Share (ARPI) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
